Exicure announces dosing of first patient in Ph1b/2 immuno-oncology trial

Clinical Research |  News | 0 Comment | 25 Feb, 2019

Exicure, a clinical stage biotechnology company developing a new class of immunomodulatory and gene regulating drugs and a pioneer in gene regulatory and immunotherapeutic drugs utiliz...Read more

Foresee Pharma announces topline results of FP-001 LMIS in prostate cancer

Clinical Research |  News | 0 Comment | 22 Feb, 2019

Foresee Pharmaceuticals, a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange has announced that the topline results of FP-001 LMIS (Leuprolide Mesylate Injectable ...Read more

Enzychem Lifesciences completes Stage 1 patient enrollment in Ph2 CRIOM study

Clinical Research |  News | 0 Comment | 22 Feb, 2019

Enzychem Lifesciences, a global biopharmaceutical company headquartered in Seoul, Korea which is dedicated to developing new drugs and APIs (Active Pharmaceutical Ingredients) has announced...Read more

Owlstone Medical partners with Shanghai Renji Hospital

Clinical Research |  News | 0 Comment | 25 Feb, 2019

Owlstone Medical, a diagnostics company developing a breathalyzer for applications in early disease detection and precision medicine, and Renji Hospital have announced a collaboration to co...Read more

Sosei Heptares initiates new clinical development programme

Clinical Research |  News | 0 Comment | 22 Feb, 2019

Sosei Group Corporation, has announced that the first healthy subject has been dosed with a novel small molecule HTL0030310 in a Phase I clinical study, marking the start of a new in-house ...Read more

Mallinckrodt presents analysis results for Therakos against aGvHD

Clinical Research |  News | 0 Comment | 21 Feb, 2019

Mallinckrodt plc, a leading global specialty pharmaceutical company has announced interim analysis results of its company-sponsored, Phase 3, single-arm, open-label, multi-center study asse...Read more

Saniona announces succesful completion of preclinical development of SAN711

Clinical Research |  News | 0 Comment | 19 Feb, 2019

Saniona, a biotech company focused on CNS and eating disorders has announced the successful completion of preclinical development of SAN711, for the treatment of chronic itching and neuropa...Read more

Navitas Life Sciences acquires DataCeutics in a $45 MM deal

Clinical Research |  News | 0 Comment | 14 Feb, 2019

Navitas Life Sciences, a TAKE Solutions Enterprise has announced that it will be acquiring Life Sciences services player, DataCeutics in North America. The acquisition, as part of the 2021...Read more

Boehringer Ingelheim, IBM to integrate blockchain tech in clinical trials

Clinical Research |  News | 0 Comment | 14 Feb, 2019

Boehringer Ingelheim (Canada) Ltd. and IBM Canada have announced at the Healthcare Information and Management Systems Society (HIMSS) conference in Orlando, Florida, their plans to explore ...Read more

Pfizer, Astellas announce results from Ph 3 ARCHES trial in men with mHSPC

Clinical Research |  News | 0 Comment | 12 Feb, 2019

Pfizer Inc. and Astellas Pharma Inc. have announced the results from the Phase 3 ARCHES trial in men with metastatic hormone-sensitive prostate cancer (mHSPC). Prostate cancer is considered...Read more

“An efficient approach to clinical trial design will have the greatest impact”

Clinical Research |  Opinion | 0 Comment | 06 Feb, 2019

The annual J.P. Morgan Healthcare Conference is the premier investor conference focused exclusively on companies defining the healthcare industry. This is the largest and most informative h...Read more

TLC appoints George Spencer-Green as CMO

Clinical Research |  News | 0 Comment | 05 Feb, 2019

Taiwan Liposome Company, a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of novel nanomedicines designed to target areas of unmet medica...Read more

Eisai, Purdue Pharma announce significant data of ph 3 clinical study

Clinical Research |  News | 0 Comment | 04 Feb, 2019

Eisai Co., Ltd. and Purdue Pharma L.P. announced a six-month results from SUNRISE 2, a long-term Phase 3 clinical study evaluating the efficacy and safety of lemborexant, an investigational...Read more

Spero Therapeutics announces initiation of SPR720 Ph 1 Clinical Trial

Clinical Research |  News | 0 Comment | 31 Jan, 2019

Spero Therapeutics,  a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multidrug-resistant (MDR) bacter...Read more

Ionis, Roche initiates pivotal study of RG6042 for Huntington's disease

Clinical Research |  News | 0 Comment | 30 Jan, 2019

Ionis Pharma, Inc. the leader in antisense therapeutics, has announced that its partner Roche has enrolled the first patient in a pivotal study of RG6042 (IONIS-HTTRx) for people livin...Read more

NIAID-sponsored trial of Ebola vaccines begins at Cincinnati Children's Hospital

Clinical Research |  News | 0 Comment | 29 Jan, 2019

A Phase 1 clinical trial of investigational vaccines intended to protect against Zaire ebolavirus (Ebola) is underway at Cincinnati Children's Hospital Medical Center in the United Sta...Read more

Dicerna announces start of Ph1 clinical trial of DCR-HBVS

Clinical Research |  News | 0 Comment | 29 Jan, 2019

Dicerna Pharmaceuticals, a leading developer of RNA interference (RNAi) therapeutics, today announced the dosing of the first human volunteer in its Phase 1 clinical trial of DCR-HBVS, the ...Read more

OliX announces clinical candidate for Geographic Atrophy treatment

Clinical Research |  News | 0 Comment | 29 Jan, 2019

OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, has announced the nomination of OLX10020 as a clinical candidate for the treatment of Geographic Atrophy (GA), which is...Read more